about
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinkingTissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.Elevated hematocrit enhances platelet accumulation following vascular injury.The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.Coagulation factor XIIIa is inactivated by plasmin.Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.Red blood cells in thrombosis.Identification and characterization of novel mutations implicated in congenital fibrinogen disordersAdvances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on HemostasisFibrinogen and fibrin: An illustrated reviewAbnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiencyFactor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in miceIllustrated review article: A new format for disseminating scientific progressThrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown causeRed blood cells modulate structure and dynamics of venous clot formation in sickle cell diseaseFactor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in miceThe factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrationsMice, men, and differences therein
P50
Q36169271-DEE19931-9EF4-40EE-9512-E94797E0D606Q36470049-3E29361D-E8F5-4F7F-8512-333202397ED4Q38934014-D3D5C179-C98D-4CEC-8654-B01EC229A749Q39453804-85B7A53F-06EE-4867-A536-599CFAFBE208Q42246877-7381F982-6719-4BD4-808C-9F5F2441CF9DQ45869234-62204160-7FA9-46F6-A22F-C6C0AD9096DEQ45873682-42E41223-51E9-43F0-9949-4A342DD832D2Q48003288-B74ACAFE-62A1-44D1-8812-B01C54C8F0BCQ57824871-6D03E09A-3F85-4F68-8E70-0A9B5C8B5F9FQ58895615-A72AFB28-F243-4D6C-95E3-87C6A91EA6A1Q64069650-50C80F47-4D83-4003-A698-AC1F179E2A0AQ88670342-94C2CEB1-15AE-4462-A971-9F4C9E462036Q89893917-030EB449-9363-4E82-84B7-26279BA47999Q90480655-775536D1-75FE-456B-A003-AC9AAE672354Q92610820-3232F36F-E813-4558-AE79-7C2DD1C31998Q92884653-EE7758CA-D057-4B3F-8FF1-BAC455622B80Q92983737-B28360CA-F311-436B-B930-677D7DAEC6FDQ92988336-144C5ED4-868D-48E1-9701-232530434A50Q93072428-37BA6C89-7205-47BE-B65E-4B68F7894F3D
P50
description
investigador
@es
researcher
@en
name
Alisa S Wolberg
@en
type
label
Alisa S Wolberg
@en
prefLabel
Alisa S Wolberg
@en
P31
P496
0000-0002-2845-2303